Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats.
作者信息
Erbler H C
出版信息
Acta Endocrinol (Copenh). 1979 Jan;90(1):147-56. doi: 10.1530/acta.0.0900147.
PMID:760354
Abstract
摘要
相似文献
1
Effect of spironolactone and its main metabolite canrenone on the renin-angiotensin-aldosterone-system during long-term treatment in rats.
Acta Endocrinol (Copenh). 1979 Jan;90(1):147-56. doi: 10.1530/acta.0.0900147.
2
Proceedings: Acute and chronic effects of the aldosterone antagonist spironolactone and its main metabolite canrenone on plasma aldosterone concentration, plasma renin activity, serum electrolytes and on the excretion of aldosterone, fluid and electrolytes in rats.研究报告：醛固酮拮抗剂螺内酯及其主要代谢产物坎利酮对大鼠血浆醛固酮浓度、血浆肾素活性、血清电解质以及醛固酮、液体和电解质排泄的急性和慢性影响
Naunyn Schmiedebergs Arch Pharmacol. 1975;287 Suppl:R52.
3
A comparison of some extra-renal effects of spironolactone and canrenone.螺内酯和坎利酮的一些肾外效应比较。
Br J Clin Pharmacol. 1979 Apr;7(4):385-92. doi: 10.1111/j.1365-2125.1979.tb00950.x.
4
Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.醛固酮拮抗剂坎利酮对人体血浆醛固酮浓度、血浆肾素活性以及醛固酮和电解质排泄的影响。
Eur J Clin Pharmacol. 1976 Feb 6;9(4):253-7. doi: 10.1007/BF00561657.
5
6
Spirolactones: clinical and pharmacologic studies.螺内酯：临床与药理学研究
Adv Nephrol Necker Hosp. 1977;7:199-215.
7
Antagonism of fludrocortisone by spironolactone and canrenone.螺内酯和坎利酮对氟氢可的松的拮抗作用。
Br J Clin Pharmacol. 1976 Feb;3(1):201-4. doi: 10.1111/j.1365-2125.1976.tb00593.x.
8
Spironolactone and canrenoate-K: relative potency at steady state.螺内酯和坎利酸钾：稳态时的相对效价。
Clin Pharmacol Ther. 1977 May;21(5):602-9. doi: 10.1002/cpt1977215602.
9
[Membrane activity of canrenone in the normotensive subject: evaluation and significance].[坎利酮在血压正常受试者中的膜活性：评估与意义]
Sem Hop. 1981;57(9-10):495-8.
10
[Clinical pharmacology. Pharmacokinetics and affinity of drugs for their receptors, Apropos of anti-aldosterone].[临床药理学。药物的药代动力学及其对受体的亲和力，关于抗醛固酮类药物]
Sem Hop Ther. 1976 Sep-Oct;52(7-8):403-6.
引用本文的文献
1
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.醛固酮受体拮抗剂治疗已确立的肺动脉高压可改善 SU5416 低氧大鼠模型的室间隔依赖性。
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L315-L332. doi: 10.1152/ajplung.00238.2021. Epub 2022 Jan 19.
Zotero 插件